Cardiopatías Familiares e xenética cardiovascular
Brigham and Women's Hospital
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Brigham and Women's Hospital (5)
2024
2023
-
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45
2022
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
2020
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
2005
-
Gene mutations in apical hypertrophic cardiomyopathy
Circulation, Vol. 112, Núm. 18, pp. 2805-2811